Zhong Zhong

Company: Ovid Therapeutics
Job title: Chief Scientific Officer
Seminars:
KCC2 Direct Activators to Modulate Neuronal Hyperexcitation in Psychosis 10:00 am
Transforming the treatment landscape for neurological disorders Reviewing a novel target which offers a promising new therapeutic avenue for neuropsychiatric, neurodevelopmental and neurodegenerative disordersRead more
day: Day Two